Eiber M - Search Results

1

Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systems.

Peschke K, Jakubowsky H, Schäfer A, Maurer C, Lange S, Orben F, Bernad R, Harder FN, Eiber M, Öllinger R, Steiger K, Schlitter M, Weichert W, Mayr U, Phillip V, Schlag C, Schmid RM, Braren RF, Kong B, Demir IE, Friess H, Rad R, Saur D, Schneider G, Reichert M. Peschke K, et al. Among authors: eiber m. EMBO Mol Med. 2022 Apr 7;14(4):e14876. doi: 10.15252/emmm.202114876. Epub 2022 Feb 4. EMBO Mol Med. 2022. PMID: 35119792 Free PMC article.

2

Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer.

Holzapfel K, Reiser-Erkan C, Fingerle AA, Erkan M, Eiber MJ, Rummeny EJ, Friess H, Kleeff J, Gaa J. Holzapfel K, et al. Among authors: eiber mj. Abdom Imaging. 2011 Apr;36(2):179-84. doi: 10.1007/s00261-010-9633-5. Abdom Imaging. 2011. PMID: 20563868

3

[Multifocal tumors in a 56-year-old male patient].

Kaissis G, Eiber M, Becker V, Holzapfel K, Rummeny EJ, Braren R. Kaissis G, et al. Among authors: eiber m. Radiologe. 2015 Nov;55(11):1009-13. doi: 10.1007/s00117-015-0037-y. Radiologe. 2015. PMID: 26515284 German. No abstract available.

4

[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.

Schwarzenböck SM, Knieling A, Souvatzoglou M, Kurth J, Steiger K, Eiber M, Esposito I, Retz M, Kübler H, Gschwend JE, Schwaiger M, Krause BJ, Thalgott M. Schwarzenböck SM, et al. Among authors: eiber m. Oncotarget. 2016 Sep 27;7(39):63747-63757. doi: 10.18632/oncotarget.11653. Oncotarget. 2016. PMID: 27572317 Free PMC article.

5

Image of the Month: Multifocal 68Ga Prostate-Specific Membrane Antigen Ligand Uptake in the Skeleton in a Man With Both Prostate Cancer and Multiple Myeloma.

Rauscher I, Maurer T, Steiger K, Schwaiger M, Eiber M. Rauscher I, et al. Among authors: eiber m. Clin Nucl Med. 2017 Jul;42(7):547-548. doi: 10.1097/RLU.0000000000001649. Clin Nucl Med. 2017. PMID: 28368889

6

A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.

Kaissis G, Ziegelmayer S, Lohöfer F, Algül H, Eiber M, Weichert W, Schmid R, Friess H, Rummeny E, Ankerst D, Siveke J, Braren R. Kaissis G, et al. Among authors: eiber m. Eur Radiol Exp. 2019 Oct 17;3(1):41. doi: 10.1186/s41747-019-0119-0. Eur Radiol Exp. 2019. PMID: 31624935 Free PMC article.

7

Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer.

Birindelli G, Drobnjakovic M, Morath V, Steiger K, D'Alessandria C, Gourni E, Afshar-Oromieh A, Weber W, Rominger A, Eiber M, Shi K. Birindelli G, et al. Among authors: eiber m. Cancers (Basel). 2021 Jul 8;13(14):3429. doi: 10.3390/cancers13143429. Cancers (Basel). 2021. PMID: 34298642 Free PMC article.

8

[¹⁸F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma.

Harder FN, Jungmann F, Kaissis GA, Lohöfer FK, Ziegelmayer S, Havel D, Quante M, Reichert M, Schmid RM, Demir IE, Friess H, Wildgruber M, Siveke J, Muckenhuber A, Steiger K, Weichert W, Rauscher I, Eiber M, Makowski MR, Braren RF. Harder FN, et al. Among authors: eiber m. EJNMMI Res. 2021 Jul 28;11(1):70. doi: 10.1186/s13550-021-00808-4. EJNMMI Res. 2021. PMID: 34322781 Free PMC article.

9

PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy.

Wang H, Amiel T, Würnschimmel C, Langbein T, Steiger K, Rauscher I, Horn T, Maurer T, Weber W, Wester HJ, Knorr K, Eiber M. Wang H, et al. Among authors: eiber m. EJNMMI Res. 2021 Aug 21;11(1):76. doi: 10.1186/s13550-021-00818-2. EJNMMI Res. 2021. PMID: 34417907 Free PMC article.

10

Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer.

Wang H, Remke M, Horn T, Schwamborn K, Chen Y, Steiger K, Weichert W, Wester HJ, Schottelius M, Weber WA, Eiber M. Wang H, et al. Among authors: eiber m. EJNMMI Res. 2023 Nov 16;13(1):99. doi: 10.1186/s13550-023-01044-8. EJNMMI Res. 2023. PMID: 37971546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page